Syndax Pharmaceuticals
IPOHome - Syndax
Public · Waltham, United States · Founded 2005 · $152.6M raised
- Headquarters
- Waltham, Massachusetts
- Employees
- 51–200
- Founded
- 2005
- Business Model
- B2B
- Website
- syndax.com
- Total Funding
- $152.6M
- Last Round
- $80.0M Series CAug 2015
- Rounds
- 4
- Type
- Public
About
Syndax is a commercial-stage biopharma developing cancer therapies for acute leukemia. Revumenib (Revuforj) FDA-approved for KMT2Ar acute leukemia.
Summary
Syndax Pharmaceuticals is a Biotech company based in Waltham, United States, founded in 2005. It has raised $152.6M in total across 4 rounds, most recently a $80.0M Series C round in Aug 2015. Investors include Royalty Pharma, Delos Capital and Fidelity Management.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Nov 2024
Sign up to see all 6 rounds
Series A through Debt Financing — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/syndax-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/syndax-pharmaceuticals" alt="Syndax Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>